Zeng; Hongkui

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zeng; Hongkui.The latest application filed is for "artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations".

Company Profile

0.8.20

Zeng; Hongkui - Seattle WA
Zeng; Hongkui - Shoreline WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Artificial Expression Constructs For Selectively Modulating Gene Expression In Selected Neuronal Cell Populations App 20220249703 - Ting; Jonathan ; et al.	2022-08-11
Artificial Expression Constructs For Selectively Modulating Gene Expression In Excitatory Cortical Neurons App 20210395780 - Graybuck; Lucas T. ; et al.	2021-12-23
Use Of Pde7 Inhibitors For The Treatment Of Movement Disorders App 20190183824 - Bergmann; John E. ; et al.	2019-06-20
G protein coupled receptor 85 and SREB3 knockout mice and uses thereof Grant 10,292,374 - Gaitanaris , et al.	2019-05-21
G Protein Coupled Receptors and Uses Thereof App 20170188555 - Gaitanaris; George A. ; et al.	2017-07-06
G Protein Coupled Receptors And Uses Thereof App 20160282365 - Gaitanaris; George A. ; et al.	2016-09-29
G Protein Coupled Receptors And Uses Thereof App 20160219845 - Gaitanaris; George A. ; et al.	2016-08-04
Use Of Pde7 Inhibitors For The Treatment Of Movement Disorders App 20160015715 - Bergmann; John E. ; et al.	2016-01-21
Use of PDE7 inhibitors for the treatment of movement disorders Grant 9,119,822 - Bergmann , et al. September 1, 2	2015-09-01
Method of identifying a compound for the treatment or prevention of obesity Grant 8,999,654 - Gaitanaris , et al. April 7, 2	2015-04-07
Use of PDE7 Inhibitors for the Treatment of Movement Disorders App 20140179717 - Bergmann; John E. ; et al.	2014-06-26
Use of PDE7 inhibitors for the treatment of movement disorders Grant 8,637,528 - Bergmann , et al. January 28, 2	2014-01-28
G Protein Coupled Receptors And Uses Thereof App 20130247233 - Gaitanaris; George A. ; et al.	2013-09-19
PDE10 inhibitors and related compositions and methods Grant 8,278,327 - Bergmann , et al. October 2, 2	2012-10-02
G Protein Coupled Receptors And Uses Thereof App 20110214189 - GAITANARIS; GEORGE A. ; et al.	2011-09-01
G Protein Coupled Receptors And Uses Thereof App 20110185439 - Gaitanaris; George A. ; et al.	2011-07-28
Use Of Pde7 Inhibitors For The Treatment Of Movement Disorders App 20110091388 - Bergmann; John E. ; et al.	2011-04-21
Pde10 Inhibitors And Related Compositions And Methods App 20110021509 - Bergmann; John E. ; et al.	2011-01-27
PDE10 inhibitors and related compositions and methods Grant 7,786,139 - Bergmann , et al. August 31, 2	2010-08-31
Use Of Pde7 Inhibitors For The Treatment Of Movement Disorders App 20100113486 - Bergmann; John E. ; et al.	2010-05-06
G Protein Coupled Receptors And Uses Thereof App 20090178153 - Gaitanaris; George A. ; et al.	2009-07-09
Pde10 Inhibitors And Related Compositions And Methods App 20080300240 - Bergmann; John E. ; et al.	2008-12-04
Use Of Pde7 Inhibitors For The Treatment Of Movement Disorders App 20080260643 - Bergmann; John E. ; et al.	2008-10-23
G Protein Coupled Receptors And Uses Thereof App 20080260744 - Gaitanaris; George A. ; et al.	2008-10-23
G protein coupled receptors and uses thereof App 20060134109 - Gaitanaris; George A. ; et al.	2006-06-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.